These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11688186)

  • 21. Does Chlamydia pneumoniae play a role in the pathogenesis of multiple sclerosis?
    Stratton CW; Mitchell WM; Sriram S
    J Med Microbiol; 2000 Jan; 49(1):1-3. PubMed ID: 10628821
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae.
    Stratton CW; Wheldon DB
    Trends Microbiol; 2006 Nov; 14(11):474-9. PubMed ID: 16996738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis.
    Parratt J; Tavendale R; O'Riordan J; Parratt D; Swingler R
    Mult Scler; 2008 Apr; 14(3):292-9. PubMed ID: 18208884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An infectious basis for multiple sclerosis: perspectives on the role of Chlamydia pneumoniae and other agents.
    Moses H; Sriram S
    BioDrugs; 2001; 15(3):199-206. PubMed ID: 11437685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis.
    Hao Q; Miyashita N; Matsui M; Wang HY; Matsushima T; Saida T
    Mult Scler; 2002 Oct; 8(5):436-40. PubMed ID: 12356213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The presence of anti-Chlamydia pneumoniae antibodies in peripheral vascular and neurological disorders].
    Gutiérrez-Fernández J; Linares-Palomino J; Fernández-Sánchez F; Guerrero-Fernández M; López Espada C; Ros-Díez E; Rodríguez Fernández M; Maroto-Vela MC
    Rev Neurol; 2001 Mar 16-31; 32(6):501-5. PubMed ID: 11353985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.
    Boman J; Roblin PM; Sundström P; Sandström M; Hammerschlag MR
    Neurology; 2000 Jan; 54(1):265. PubMed ID: 10636169
    [No Abstract]   [Full Text] [Related]  

  • 28. Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?
    Hammerschlag MR; Ke Z; Lu F; Roblin P; Boman J; Kalman B
    J Clin Microbiol; 2000 Nov; 38(11):4274-6. PubMed ID: 11060110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis.
    Furrows SJ; Hartley JC; Bell J; Silver N; Losseff N; Stevenson S; Chapman M; Thompson EJ; Ridgway GL; Giovannoni G
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):152-4. PubMed ID: 14707329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids.
    Ikejima H; Haranaga S; Takemura H; Kamo T; Takahashi Y; Friedman H; Yamamoto Y
    Clin Diagn Lab Immunol; 2001 May; 8(3):499-502. PubMed ID: 11329447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum reactivity to Chlamydia trachomatis and C. pneumoniae antigens in patients with documented infection and in healthy children by microimmunofluorescence and immunoblotting techniques.
    Gonen R; Shemer-Avni Y; Csángó PA; Sarov B; Friedman MG
    APMIS; 1993 Sep; 101(9):719-26. PubMed ID: 8240791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis.
    Layh-Schmitt G; Bendl C; Hildt U; Dong-Si T; Jüttler E; Schnitzler P; Grond-Ginsbach C; Grau AJ
    Ann Neurol; 2000 May; 47(5):652-5. PubMed ID: 10805338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlamydia pneumoniae seropositivity in Iranian patients with multiple sclerosis: a pilot study.
    Aghaei M; Ashtari F; Bahar M; Falahian MR
    Neurol Neurochir Pol; 2011; 45(2):128-31. PubMed ID: 21574116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Chlamydia in Multiple Sclerosis.
    Ivanova MV; Kolkova NI; Morgunova EY; Pashko YP; Zigangirova NA; Zakharova MN
    Bull Exp Biol Med; 2015 Sep; 159(5):646-8. PubMed ID: 26468024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection with Chlamydia pneumoniae and risk of multiple sclerosis.
    Munger KL; Peeling RW; Hernán MA; Chasan-Taber L; Olek MJ; Hankinson SE; Hunter D; Ascherio A
    Epidemiology; 2003 Mar; 14(2):141-7. PubMed ID: 12606878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Chlamydia pneumoniae with central nervous system disease.
    Stratton CW; Sriram S
    Microbes Infect; 2003 Nov; 5(13):1249-53. PubMed ID: 14623021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of serum oligoclonal antibody responses to Chlamydophila pneumoniae in multiple sclerosis.
    Parratt J
    Eur Neurol; 2005; 54(4):238; author reply 239. PubMed ID: 16401902
    [No Abstract]   [Full Text] [Related]  

  • 38. Viruses and multiple sclerosis.
    Gilden DH
    JAMA; 2001 Dec; 286(24):3127-9. PubMed ID: 11754680
    [No Abstract]   [Full Text] [Related]  

  • 39. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J; de los Milagros Bassani Molinas M
    J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis.
    Ke Z; Lu F; Roblin P; Boman J; Hammerschlag MR; Kalman B
    Ann Neurol; 2000 Sep; 48(3):400. PubMed ID: 10976653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.